Akari Therapeutics (AKTX) announced the appointment of Torsten Hombeck, Ph.D. as CFO. Prior to joining Akari, Dr. Hombeck served as the CFO, Corporate Secretary and SVP at Aspira Women’s Health (AWH). Prior to that, Dr. Hombeck served as the CFO of Akari Therapeutics from 2019-June 2023 where he raised over $50 million during his tenure.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKTX: